Skip to content
Visit us at
www.anandandanand.com
Search
PATENTS REWIND : AN ANAND AND ANAND BLOG
Category:
Life Sciences
Export within ambit of Bolar exemption
Trastuzumab “can” be sold as a bio similar to Roche’s Trastuzumab
Writ for Enzalutamide admitted by the DHC
Generation of foreign exchange is not in public interest
Evidence is only a proof of pleadings
Notifications under Section 26A of the Drugs and Cosmetics Act declared legally untenable
Section 24(5) declared void
NATIONAL BIODIVERSITY ACT: ISSUES AND RECOMMENDATIONS
Cancer drug (Enzalutamide) Patent application refused
Etanercept applications granted by the IPO
Previous Page
Next Page
Subscribe
Subscribed
Patents Rewind - An Anand and Anand Blog
Join 108 other subscribers
Sign me up
Already have a WordPress.com account?
Log in now.
Patents Rewind - An Anand and Anand Blog
Subscribe
Subscribed
Sign up
Log in
Report this content
View site in Reader
Manage subscriptions
Collapse this bar
Patents Rewind - An Anand and Anand Blog 